PMAM
AMAG

Picton Mahoney Asset Management’s AMAG Pharmaceuticals AMAG Stock Holding History

Picton Mahoney Asset Management’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-44,400
Closed -$1.34M – 378
2015
Q4 		$1.34M Buy
+44,400
New +$1.43M 0.08% 153

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return

Picton Mahoney Asset Management's AMAG Position: Q1 2016 in Review

Picton Mahoney Asset Management sold out of AMAG Pharmaceuticals (AMAG) in Q1 2016, closing a stake of 44,400 shares — an estimated $1.34M sold.

Picton Mahoney Asset Management first reported a position in AMAG in Q4 2015 and held it in 1 quarter. The position peaked at $1.34M in Q4 2015. 185 funds tracked by Wall St. Rank hold AMAG as of Q1 2016.

  • Picton Mahoney Asset Management reported no remaining AMAG Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 44,400 AMAG Pharmaceuticals shares in Q1 2016, an estimated $1.34M.
  • Picton Mahoney Asset Management first reported a position in AMAG Pharmaceuticals in Q4 2015 and held it in 1 quarter.
  • Picton Mahoney Asset Management's AMAG Pharmaceuticals position peaked at $1.34M in Q4 2015.
  • 185 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2016.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2016, filed 11 May 2016.